Bull/Bear Index 45.0/100
→
Aprogen Biologics conducts 2 billion won capital increase
KOSPI-listed Aprogen Biologics announced a 2.01 billion won third-party allocation capital increase.
Key takeaway
"Aprogen Biologics conducts 2 billion won capital increase" — BullBear's AI rates this story as a mixed, direction-neutral signal, with a market-impact score of 15 out of 100. KOSPI-listed Aprogen Biologics announced a 2.01 billion won third-party allocation capital increase. Reported by Maeil Business on April 13, 2026. The call is verified against the actual 24-hour price move on BullBear's public conviction ledger.
Get the next high-impact catalyst
Telegram alerts when our AI scores a story 80+/100 impact (~1-3 per day, no spam). Verified 30d hit rate 53.4%.
Join Telegram channel
or scan with phone →